prenatal diagnosis of genetic diseases Flashcards
non-invasive versus invasive tests: explain the use of non-invasive tests (maternal serum screening, ultrasound, NIPT) and the use of invasive tests (amniocentesis, chorionic villus sampling)
non-invasive tests
ultrasound, MRI, NIPD
ultrasound
early/dating scan; nuchal translucency and nasal bone (Down); high level/anomaly scan
MRI
high level/anomaly scan can be diagnostic; show soft markers for other problems; nasal bone=>increase sensitivity to Down screening; foetal cardiac scans
non-invasive prenatal testing (NIPD) with cell-free foetal DNA (cffDNA): purpose
conducted especially if chance of X-linked condition; determines sex of baby (foetal DNA in maternal blood can isolate DNA and look for (SR)Y chromosome); tests for aneuploidy and some autosomal dominant monogenic diseases
non-invasive prenatal testing (NIPD) with cell-free foetal DNA (cffDNA): advantages
reduce no. invasive tests; no risk miscarriage; offered early
non-invasive prenatal testing (NIPD) with cell-free foetal DNA (cffDNA): disadvantages
if multiple pregnancies, cannot tell which foetus DNA is from unless identical twins; if mother has high BMI, relative proportion of foetal DNA is lower; ethical issues; invasive test may still be needed
minimally invasive maternal serum screening
blood test to mum; detects increased risk of trisomy 21, 17 or neural tube defects; 1st and 2nd trimesters
when are invasive tests done
when known risk shown by prenatal testing and if known genetic condition in family (have QF-PCR test for trisomy 13, 18 and 21); carry miscarriage risk
invasive tests
chorionic villus sampling (CVS), amniocentesis, foetal blood sampling
chorionic villus sampling (CVS)
11-14 weeks; 1-2% chance miscarriage; abdomen/vagina; part of developing placenta has same DNA as foetus; tertiary referral centre
amniocentesis
16 weeks; requires ultrasound; amniotic fluid sample with foetal cells via needle puncture through maternal abdomen and amniotic membranes; 1% chance miscarriage
foetal blood sampling
assesses foetal anaemia